Researchers developed a new mouse model that replicates long COVID-19 more accurately than current models. Their findings could lead to new treatments.

A chip the size of a pack of cards uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable cell therapy manufacturing.

The building will serve as a hub for research on the development of immunology-based treatments.

With support from The Marcus Foundation, an MIT neuroscientist and a Harvard Medical School immunologist will study the “fever effect” in an effort to devise therapies that mimic its beneficial effects.

Asthma attacks can result from immune cells overreacting to a harmless allergen. Tamping down iron levels in certain immune cells can help control their activity.

Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.

When faced with a threat, T cells have the decision-making flexibility to both clear out the pathogen now and ready themselves for a future encounter.

Whitehead Institute Member Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.

Team-based targeted projects, multi-mentor fellowships ensure that scientists studying social cognition, behavior, and autism integrate multiple perspectives and approaches to pressing questions.